Nkg2d receptor activation drives primary transplantation outcomes

HIGHLIGHTS

• who: Daniel R. Calabrese and colleagues from the DepartmentMedicine, UCSF, San Francisco, California, USA have published the research: NKG2D receptor activation drives primary transplantation outcomes, in the Journal: (JOURNAL)
• what: The authors focused on the proteins with increased gene transcription and found that IL-15 were all increased relative to hypoxic airway epithelial_cells and normoxic airway epithelial_cells.

SUMMARY

Lung transplantation is a life-prolonging therapy for patients with end-stage lung disease. PGD has no known medical therapies, accounts for half of the first-year mortality after lung transplantation, and is . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.